Two Sigma Investments’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Two Sigma Investments’s Portfolio MRTX Stock Details MRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-124,700	Closed	-$8.37M	–	2935
2022 Q2	$8.37M	Sell	124,700 -99,577	-44%	-$6.33M	0.03%	571
2022 Q1	$18.4M	Buy	+224,277	New	+$22.9M	0.05%	408
2021 Q2	–	Sell	-173,216	Closed	-$29.7M	–	4701
2021 Q1	$29.7M	Buy	173,216 +8,560	+5%	+$1.69M	0.08%	298
2020 Q4	$36.2M	Buy	164,656 +156,746	+1,982%	+$33.9M	0.1%	219
2020 Q3	$1.31M	Buy	7,910 +610	+8%	+$83.5K	﹤0.01%	1580
2020 Q2	$833K	Buy	+7,300	New	+$708K	﹤0.01%	1650
2020 Q1	–	Sell	-19,750	Closed	-$2.54M	–	3984
2019 Q4	$2.54M	Sell	19,750 -30,731	-61%	-$2.96M	0.01%	1398
2019 Q3	$3.93M	Buy	50,481 +3,530	+8%	+$331K	0.01%	988
2019 Q2	$4.84M	Buy	+46,951	New	+$3.66M	0.02%	915
2018 Q3	–	Sell	-12,000	Closed	-$592K	–	3700
2018 Q2	$592K	Buy	+12,000	New	+$453K	﹤0.01%	2534
2016 Q3	–	Sell	-116,581	Closed	-$637K	–	3446
2016 Q2	$637K	Buy	+116,581	New	+$1.86M	﹤0.01%	2080
2014 Q3	–	Sell	-11,279	Closed	-$226K	–	2114
2014 Q2	$226K	Buy	+11,279	New	+$218K	﹤0.01%	1940

Other funds holding MRTX

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Two Sigma Investments's MRTX Position: Q3 2022 in Review

Two Sigma Investments sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q3 2022, closing a stake of 124,700 shares — an estimated $8.37M sold.

Two Sigma Investments first reported a position in MRTX in Q2 2014 and held it in 12 quarters. The position peaked at $36.2M in Q4 2020. 243 funds tracked by Wall St. Rank hold MRTX as of Q3 2022.

Two Sigma Investments reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Two Sigma Investments sold 124,700 Mirati Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $8.37M.
Two Sigma Investments first reported a position in Mirati Therapeutics, Inc. Common Stock in Q2 2014 and held it in 12 quarters.
Two Sigma Investments's Mirati Therapeutics, Inc. Common Stock position peaked at $36.2M in Q4 2020.
243 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Two Sigma Investments's 13F filing for Q3 2022, filed 14 Nov 2022.